IASLC-WCLC-I 2020 - 2020 IASLC WCLC Presidential Symposium (Virtual Meeting)
Aug 08 - Aug 08, 2020 | SingaporeSingapore
LARVOL is not affiliated with 2020 IASLC WCLC Presidential Symposium (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 5 abstracts linked to Trials
[VIRTUAL] ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC
[VIRTUAL] Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3
[VIRTUAL] First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
[VIRTUAL] First-line Sintilimab Plus Platinum-Based Chemotherapy Prolongs PFS in Advanced Nonsquamous NCLC
[VIRTUAL] eXalt3 Findings Support Ensartinib as a First-Line Treatment Option in ALK-positive NSCLC